Peng Liang Buys Handful Of Shares In Clover Biopharmaceuticals

Simply Wall StOct 18 07:34

Clover Reports Positive Phase 1 Data for Combination Respiratory Vaccines and RSV Re-Vaccination; Shares Down 4%

MT NewswiresOct 15 11:48

Clover Biopharmaceuticals (02197.HK) reports positive data from two clinical trials.

Clover Biopharmaceuticals-B (02197.HK) announced positive preliminary data from two ongoing clinical trials, including: a Phase I clinical trial conducted in Australia to evaluate the respiratory combination vaccine candidates SCB-1022 and SCB-1033 in a head-to-head comparison with SCB-1019, targeting an elderly population that has not previously received any RSV vaccine; and a Phase I clinical trial conducted in the United States for a head-to-head evaluation of repeated dosing of SCB-1019 versus AREXVY, enrolling participants who had received their first dose at least two epidemic seasons prior to enrollment.

AASTOCKSOct 14 21:33

Clover Biopharmaceuticals-B (02197) announced positive data from the Phase I clinical trials of its respiratory combination vaccine (RSV-hMPV-PIV3) and RSV vaccine booster in elderly populations.

Clover Biopharmaceuticals-B (02197) announced the release of positive preliminary data from two ongoing clinical trials, based on...

Zhitong FinanceOct 14 18:09

Hong Kong Stock Market Movements | Broad Decline in Pharmaceutical Stocks: Clover Biopharmaceuticals-B (02197) Plummets Over 14%, RemeGen (09995) Drops More Than 11%

Pharmaceutical stocks generally plummeted. As of the time of writing, Clover Biopharmaceuticals-B (02197) fell 14.43% to HKD 2.49; RemeGen Co., Ltd. (09995) dropped 11.54% to HKD 105.4.

Zhitong FinanceOct 9 13:54

Changfeng Pharmaceuticals surged over 160% on its debut! The entire sector is taking off, with the pharmaceutical newcomer Xuanzhu Biologics-B closing subscription on the 10th.

This year, newly listed pharmaceutical stocks have delivered exceptional returns, with over 80% closing higher on their debut. The top five performers all surged by more than 100% on their first day. Today's listing of Changfeng Pharmaceuticals yielded the highest return, with a gain of nearly HKD 12,000 per lot.

Securities Daily ChinaOct 8 16:27